MalnutritionNCT01148641
Acceptability of LNS for Infants and Young Children in Guatemala
An observational study of Malnutrition, run by University of California, Davis at 1 site in Guatemala.
Trial summary
This study aims to assess the acceptability of lipid-based nutrient supplements (LNS) for use as nutritional supplements for infants and young children in Guatemala. The study was conducted in three phases. Read more about this study
- Who is it for?
- Ages 6 to 18 monthsHealthy volunteers can take part
- Conditions the study is for
- Malnutrition
- What is being tested?
- LNS
- How many people
- 43 participants
- Where
- 1 siteGuatemala
- Study dates
- May 2010to Nov 2010
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 18 months
- All sexes
- Healthy volunteers accepted
- Child
Study population: - Children 6-18 months of age.
Who may be able to join
- Children 6-18 months of age.
- Consuming solid foods for at least the past 30 days.
- Apparently healthy and not presently suffering from an acute illness (e.g., fever, diarrhea, acute respiratory tract infection).
- No known allergy to peanuts or other food products (as reported on the screening questionnaire by the mother/primary caregiver).
- Not severely malnourished [mid-upper arm circumference (MUAC) > 115 mm].
- Maternal/caregiver willingness to feed the infant with LNS over a maximum 3 test days, and over the 2 week home-use period, and report on his/her consumption and reactions and practices for daily use. Willingness to participate in discussion groups.
- Planning to remain in study area for at least the following three weeks.
Who cannot join
- Children under 6 months of age.
- All subjects with known peanut, soy or milk allergies.
- In poor health or ill at the time of recruitment.
- Severely malnourished children [mid-upper arm circumference (MUAC) < 115 mm].
- Not willing to participate in study procedures.
- Leaving the study area in the following three weeks.
Trial locations and contacts
1 site in 1 country.
Guatemala1 site
Fundacion de la Caficultura para el Dessarrollo Rural (FUNCAFE)
Mazatenango, Departamento de Suchitepéquez, zona 1
About this study
Official title: Acceptability of Lipid-based Nutrient Supplements (LNS) for Infants and Young Children in Guatemala
This study aims to assess the acceptability of lipid-based nutrient supplements (LNS) for use as nutritional supplements for infants and young children in Guatemala.
The study was conducted in three phases. Phase 1 was a test-feeding to compare the acceptability of two different flavors of LNS (peanut and cinnamon) in infants and young children and their mothers or caregivers in terms of taste, smell and texture, as well as amount of the test-dose consumed. In Phase 2, children in the Phase 1 trial received a 2-week supply of one of the LNS products, which they consumed daily in their homes for 14 days under real-life conditions. Direct observation of supplement use and in-depth interviews with mothers, caregivers and health staff providing services in communities will be part of this phase too. In Phase 3, focus group discussions (FGD) were held with participants (mothers and caregivers) as well as with health staff providing services in communities to discuss different aspects of infant and child feeding and best ways for the LNS product to be used in the context of Guatemala.
We hypothesized that both flavors of LNS would be accepted by Guatemalan infants and young children children and their mothers or caregivers.
Read the detailed description
The study was carried out in two communities in the Suchitepéquez Department in partnership with Funcafé, a NGO subcontracted by the Ministry of Health (MOH) to implement the Programa de Extension de Cobertura (PEC) in Suchitepéquez. PEC provides basic medical care in remote communities that have limited access to MOH's health centers. This acceptability study was conducted in communities where PEC was implemented by Funcafé.
The children were randomly selected from a list of beneficiaries of PEC served by Funcafé and invited to participate. Eligibility for participation in the study was determined at the time of recruitment in the homes of potential participants, by administration of a screening questionnaire by study staff.
All caregivers who completed the home use trial were invited to participate in the FGD. Funcafé staff members (i.e. Institutional facilitators, Community facilitators and Community monitors) were randomly selected from the employee roster and potential participants were invited to participate in FGD using a standard recruitment script.
The study was approved by the IRB of the University of California, Davis. Unawareness of whether a child was intolerant of peanut or milk products did not prevent participation, but the child was provided with a small dose of LNS (~5 g) and asked to remain under observation by study staff for at least one hour. After this initial test, caregivers were also given the project's mobile phone number to call in case there were any symptoms during the next few hours. No allergic reactions or other adverse effects were observed or reported in any subject.
During the Test-feeding trial, the order of the versions of LNS tested was randomly determined for each subject. At the first home visit after recruitment (Day 0), the primary caregivers of the children were given an orientation about LNS. During the orientation, background data (e.g., socioeconomic and demographic information) were collected using a structured questionnaire and the experimental procedures were practiced, including initial tasting of the LNS mixed with food and completion of the tasting questionnaire, but no data on amount consumed or organoleptic preferences were recorded. The second home visit was Test Day 1, during which the actual tasting was recorded. All children were apparently healthy and had not eaten any food (including breast milk) during the previous hour, but during that time water was allowed. Caregivers were asked to provide 40 g (~3 tablespoons) of the complementary food they usually give to their children that was available at home, to which 10 g (~2 teaspoons) of LNS were mixed. The mother/caregiver of the child was asked to consume one teaspoon of the LNS + food mixture (~ 5 g), and then to feed the rest (~ 45 g) to the child after the mixture was re-weighed. The mother or caretaker rated the mixture's color, aroma, flavor and consistency based on her own opinion, and her perception of the infant's degree of liking using a 5-point pictorial hedonic scale (i.e., dislike very much, dislike, neutral, like, like very much). In order to test the different flavored LNS a third home visit was conducted (Test Day 2). The same procedures described above for Test Day 1 were followed on Day 2, but each child tasted the other LNS flavor. No overall or organoleptic (i.e., color, odor, taste and consistency) preferences were assessed on Day 2. Thus, total participation in this phase lasted 3 days, including the initial orientation day. At each test-feeding day, we collected data on infant's health (i.e., nasal discharge, cough, difficulty breathing, fever, diarrhea, vomit/nausea, ear infection, and any other symptom) and any possible reaction to the test meal.
For the Home use trial, primary caregivers of children who participated in the test-feeding trial received a two-week supply of LNS, which they were asked to add to their infants' prepared food each day. The daily ration of LNS was 20 g/day, provided in two 10-g sachets. In order to avoid bias, the LNS flavor to be distributed during the home-use trial was randomly assigned without taking into account the child's preference (if any) as explained above. To ensure that subjects consumed the entire daily ration, caregivers were instructed, to mix each sachet with 2-3 tablespoons of the home-prepared food, to be fed to the child before the rest of the food was offered.
After the end of the first week of supplementation, a field worker visited the household of each participant to count the empty (used) sachets and ask questions about any child illness. At the end of two weeks, a field worker visited each participant in his/her home to repeat the morbidity questionnaire and conduct an exit interview with the mother/caregiver to assess their perceptions, use and possible intra-household distribution of the product, ease/difficulty of providing the supplement 2 times/day, and foods used to mix with the supplement.
In addition, open ended questions were asked at the exit interview to explore the caregivers' views about important characteristics of foods appropriate for infants and young children, opportunities and barriers to using a nutrient supplement "just for children of a certain age" in the family, perceptions of the use of LNS for children, and recognition of the problem of malnutrition in their communities.
The FGD were led by an experienced focus group facilitator, assisted by a note-taker who audio-recorded the discussions and took notes on group dynamics and non-verbal interactions between participants. Each focus group included 8-10 participants, and lasted for approximately 60-90 minutes.
Four FGD (two per community) were conducted with primary caregivers of the children who had consumed LNS during the test-feeding and the home-use trial. The main purpose of the FGD was to get input on appropriate supplement names and packaging designs for the LNS product in Guatemala, flavors appropriate for infants and young children, and appropriate messages for promotion of LNS for children. A brainstorming approach was used to explore possible names for the supplement, followed by secret vote to short list the names based on participants' preferences. Exploration of ideas about packaging designs started with drawings which were then organized by theme. A discussion to generate consensus on the key elements that the label should include was facilitated. A group design for the packaging was the final product of FGD.
The main objective of the FGD with Funcafé personnel was to elicit their opinion on how the LNS could be incorporated into Funcafé's program operation.
- Conditions
- Malnutrition
- Being tested
- LNS
- Keywords
- Lipid-based supplements, LNS, Acceptability, Infant nutrition, Guatemala, Malnutrition
- Medical subject headings
- Malnutrition
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
LNSDietary supplement
Also called Lipid-based nutrient supplement
Infants and young children will receive 10 g of LNS for test trial during 3 consecutive days (crossover design) and thereafter, 20 g per day for 14 days.
| Study group | Role | What they receive |
|---|---|---|
| LNS-regular | Lipid-based nutrient supplement, regular (peanut) flavor Receives: Dietary Supplement: LNS | |
| LNS-cinnamon | Lipid-based nutrient supplement, cinnamon flavor Receives: Dietary Supplement: LNS |
What is being measured
The primary outcome is the main question the study is designed to answer.
amount of LNS consumed
Amount of LNS consumed in the test trial in grams
Measured: 2 weeks
time of consumption
Avg how long it takes to eat the LNS mins
Measured: 2 weeks
amount of LNS sachets consumed in the home-use trial
# of sachets consumed
Measured: 2 weeks
Secondary outcomes (1)
qualitative assessment of mothers and caregivers opinions
Focus group discussion (qualitative results) discuss different aspects of infant and child feeding and best ways for the LNS product to be used in the context of Guatemala.
Measured: 2 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jun 2010 (estimated)
- Study startMay 2010
- Primary completionJul 2010
- Study completionNov 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MalnutritionStudies of the same condition, open and under way.
- More trials run by University of California, DavisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case crossover
- Time perspective
- Prospective
- Enrolment
- 43 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of California, Davis
- Sponsor type
- University, hospital or other
- Collaborators
- FHI 360
- Responsible party
- Sponsor
- Investigators
- Kathryn G Dewey, PhD, Principal investigator, University of California, Davis
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01148641
- Sponsor's protocol ID
- 201017829
- Status last verified
- Jan 2018
- First submitted
- 18 Jun 2010
- Last updated
- 29 Jan 2018
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Jan 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Acceptability of Lipid-based Nutrient Supplements (LNS) for Infants and Young Children in Guatemala
- ClinicalTrials.gov ID
- NCT01148641
- Acronym / sponsor ID
- 201017829
- Conditions
- Malnutrition
- Keywords
- Lipid-based supplements, LNS, Acceptability, Infant nutrition, Guatemala, Malnutrition
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 43 participants (actual)
- Lead sponsor
- University of California, DavisUniversity, hospital or other
- Collaborators
- FHI 360
- Study start
- May 2010
- Primary completion
- Jul 2010 (actual)
- Study completion
- Nov 2010 (actual)
- First posted
- 22 Jun 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to assess the acceptability of lipid-based nutrient supplements (LNS) for use as nutritional supplements for infants and young children in Guatemala.
The study was conducted in three phases. Phase 1 was a test-feeding to compare the acceptability of two different flavors of LNS (peanut and cinnamon) in infants and young children and their mothers or caregivers in terms of taste, smell and texture, as well as amount of the test-dose consumed. In Phase 2, children in the Phase 1 trial received a 2-week supply of one of the LNS products, which they consumed daily in their homes for 14 days under real-life conditions. Direct observation of supplement use and in-depth interviews with mothers, caregivers and health staff providing services in communities will be part of this phase too. In Phase 3, focus group discussions (FGD) were held with participants (mothers and caregivers) as well as with health staff providing services in communities to discuss different aspects of infant and child feeding and best ways for the LNS product to be used in the context of Guatemala.
We hypothesized that both flavors of LNS would be accepted by Guatemalan infants and young children children and their mothers or caregivers.
Detailed description
The study was carried out in two communities in the Suchitepéquez Department in partnership with Funcafé, a NGO subcontracted by the Ministry of Health (MOH) to implement the Programa de Extension de Cobertura (PEC) in Suchitepéquez. PEC provides basic medical care in remote communities that have limited access to MOH's health centers. This acceptability study was conducted in communities where PEC was implemented by Funcafé.
The children were randomly selected from a list of beneficiaries of PEC served by Funcafé and invited to participate. Eligibility for participation in the study was determined at the time of recruitment in the homes of potential participants, by administration of a screening questionnaire by study staff.
All caregivers who completed the home use trial were invited to participate in the FGD. Funcafé staff members (i.e. Institutional facilitators, Community facilitators and Community monitors) were randomly selected from the employee roster and potential participants were invited to participate in FGD using a standard recruitment script.
The study was approved by the IRB of the University of California, Davis. Unawareness of whether a child was intolerant of peanut or milk products did not prevent participation, but the child was provided with a small dose of LNS (~5 g) and asked to remain under observation by study staff for at least one hour. After this initial test, caregivers were also given the project's mobile phone number to call in case there were any symptoms during the next few hours. No allergic reactions or other adverse effects were observed or reported in any subject.
During the Test-feeding trial, the order of the versions of LNS tested was randomly determined for each subject. At the first home visit after recruitment (Day 0), the primary caregivers of the children were given an orientation about LNS. During the orientation, background data (e.g., socioeconomic and demographic information) were collected using a structured questionnaire and the experimental procedures were practiced, including initial tasting of the LNS mixed with food and completion of the tasting questionnaire, but no data on amount consumed or organoleptic preferences were recorded. The second home visit was Test Day 1, during which the actual tasting was recorded. All children were apparently healthy and had not eaten any food (including breast milk) during the previous hour, but during that time water was allowed. Caregivers were asked to provide 40 g (~3 tablespoons) of the complementary food they usually give to their children that was available at home, to which 10 g (~2 teaspoons) of LNS were mixed. The mother/caregiver of the child was asked to consume one teaspoon of the LNS + food mixture (~ 5 g), and then to feed the rest (~ 45 g) to the child after the mixture was re-weighed. The mother or caretaker rated the mixture's color, aroma, flavor and consistency based on her own opinion, and her perception of the infant's degree of liking using a 5-point pictorial hedonic scale (i.e., dislike very much, dislike, neutral, like, like very much). In order to test the different flavored LNS a third home visit was conducted (Test Day 2). The same procedures described above for Test Day 1 were followed on Day 2, but each child tasted the other LNS flavor. No overall or organoleptic (i.e., color, odor, taste and consistency) preferences were assessed on Day 2. Thus, total participation in this phase lasted 3 days, including the initial orientation day. At each test-feeding day, we collected data on infant's health (i.e., nasal discharge, cough, difficulty breathing, fever, diarrhea, vomit/nausea, ear infection, and any other symptom) and any possible reaction to the test meal.
For the Home use trial, primary caregivers of children who participated in the test-feeding trial received a two-week supply of LNS, which they were asked to add to their infants' prepared food each day. The daily ration of LNS was 20 g/day, provided in two 10-g sachets. In order to avoid bias, the LNS flavor to be distributed during the home-use trial was randomly assigned without taking into account the child's preference (if any) as explained above. To ensure that subjects consumed the entire daily ration, caregivers were instructed, to mix each sachet with 2-3 tablespoons of the home-prepared food, to be fed to the child before the rest of the food was offered.
After the end of the first week of supplementation, a field worker visited the household of each participant to count the empty (used) sachets and ask questions about any child illness. At the end of two weeks, a field worker visited each participant in his/her home to repeat the morbidity questionnaire and conduct an exit interview with the mother/caregiver to assess their perceptions, use and possible intra-household distribution of the product, ease/difficulty of providing the supplement 2 times/day, and foods used to mix with the supplement.
In addition, open ended questions were asked at the exit interview to explore the caregivers' views about important characteristics of foods appropriate for infants and young children, opportunities and barriers to using a nutrient supplement "just for children of a certain age" in the family, perceptions of the use of LNS for children, and recognition of the problem of malnutrition in their communities.
The FGD were led by an experienced focus group facilitator, assisted by a note-taker who audio-recorded the discussions and took notes on group dynamics and non-verbal interactions between participants. Each focus group included 8-10 participants, and lasted for approximately 60-90 minutes.
Four FGD (two per community) were conducted with primary caregivers of the children who had consumed LNS during the test-feeding and the home-use trial. The main purpose of the FGD was to get input on appropriate supplement names and packaging designs for the LNS product in Guatemala, flavors appropriate for infants and young children, and appropriate messages for promotion of LNS for children. A brainstorming approach was used to explore possible names for the supplement, followed by secret vote to short list the names based on participants' preferences. Exploration of ideas about packaging designs started with drawings which were then organized by theme. A discussion to generate consensus on the key elements that the label should include was facilitated. A group design for the packaging was the final product of FGD.
The main objective of the FGD with Funcafé personnel was to elicit their opinion on how the LNS could be incorporated into Funcafé's program operation.
Study design
- Observational model
- Case crossover
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| LNS-regular | – | Dietary Supplement: LNSLipid-based nutrient supplement, regular (peanut) flavor |
| LNS-cinnamon | – | Dietary Supplement: LNSLipid-based nutrient supplement, cinnamon flavor |
Who may qualify
- Ages
- 6 to 18 months
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- - Children 6-18 months of age.
Key inclusion criteria (7 listed)
- Children 6-18 months of age.
- Consuming solid foods for at least the past 30 days.
- Apparently healthy and not presently suffering from an acute illness (e.g., fever, diarrhea, acute respiratory tract infection).
- No known allergy to peanuts or other food products (as reported on the screening questionnaire by the mother/primary caregiver).
- Not severely malnourished [mid-upper arm circumference (MUAC) > 115 mm].
Key exclusion criteria (6 listed)
- Children under 6 months of age.
- All subjects with known peanut, soy or milk allergies.
- In poor health or ill at the time of recruitment.
- Severely malnourished children [mid-upper arm circumference (MUAC) < 115 mm].
- Not willing to participate in study procedures.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| LNSAlso: Lipid-based nutrient supplementInfants and young children will receive 10 g of LNS for test trial during 3 consecutive days (crossover design) and thereafter, 20 g per day for 14 days. | Dietary supplement | LNS-cinnamon, LNS-regular |
Primary outcome
amount of LNS consumed
Time frame: 2 weeks
Amount of LNS consumed in the test trial in grams
time of consumption
Time frame: 2 weeks
Avg how long it takes to eat the LNS mins
amount of LNS sachets consumed in the home-use trial
Time frame: 2 weeks
# of sachets consumed
1 secondary outcome
qualitative assessment of mothers and caregivers opinions
Time frame: 2 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jan 2018.
Related trials for Malnutrition
RecruitingPhase 1/2
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
X-linked Hypophosphatemia
Recruiting
Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
Diabetes Mellitus, Type 2, Nutrition Poor
Active, not recruiting
Evaluation of Personalized Nutritional Intervention on Wound Healing of Cutaneous Ulcers in Diabetics
Foot, Diabetic
Active, not recruitingPhase 2
Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan
Environmental Enteric Dysfunction (EED), Stunting
Not yet recruitingObservational study
Biomarkers in EV Associated With Marrow Adiposity in Anorexia
Anorexia Nervosa Restricting Type, Anorexia Nervosa (DSM-IV Revised Criteria)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kathryn G Dewey, PhD principal investigator
University of California, Davis
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Malnutrition, run by University of California, Davis at 1 site in Guatemala.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Guatemala. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
amount of LNS consumed (time frame: 2 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2018.